KEVIN M. LALANDE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN M. LALANDE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN M. LALANDE. KEVIN M. LALANDE is a Director in LUMOS PHARMA, INC. ($NLNK) and a Director in Molecular Templates, Inc. ($THLD) and a Director in LDR HOLDING CORP ($LDRH).
Address: 13785 RESEARCH BLVD., SUITE 200 AUSTIN 78750 TX
Companies in which KEVIN M. LALANDE is an Insider
LDR HOLDING CORP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of KEVIN M. LALANDE: Director
Holdings: 0 shares
Latest Transaction: Jul 13 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LUMOS PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN M. LALANDE: Director
Holdings: 1,076 shares
Current Value: $14,709
Latest Transaction: May 24 2021
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Molecular Templates, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN M. LALANDE: Director
Holdings: 6,097,298 shares
Current Value: $3,719,352
Latest Transaction: Sep 18 2020
$MTEM Market Capitalization: $41.30M
$MTEM Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KEVIN M. LALANDE
Sentiment: All, LDRH, NLNK, MTEM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2021 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Option Exercise | A | 10.36 | 2,910 | 30,148 | 2,910 | |
| May 24 2021 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Grant | A | 0.00 | 367 | 0 | 1,076 | 709 to 1.1 K (+51.76 %) |
| Sep 18 2020 | MTEM | Molecular Template ... | LALANDE KEVIN M. | Director | Sell | S | 13.05 | 500,000 | 6,525,000 | 6,097,298 | 6.6 M to 6.1 M (-7.58 %) |
| May 22 2020 | MTEM | Molecular Template ... | LALANDE KEVIN M. | Director | Sell | S | 16.51 | 300,000 | 4,953,000 | 6,597,298 | 6.9 M to 6.6 M (-4.35 %) |
| May 04 2020 | MTEM | Molecular Template ... | LALANDE KEVIN M. | Director | Sell | J | 0.00 | 1,000,000 | 0 | 6,897,298 | 7.9 M to 6.9 M (-12.66 %) |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |